Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CANQF CANAQUEST MEDICAL CORPORATION
0.1700.0000.00%
Close
01/31 16:00 ET
High
0.000
Open
0.170
Turnover
0.00
Low
0.000
Pre Close
0.170
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
CBD Combined With Essential Fatty Acids Is 40% More Efficient In Epilepsy Seizure Reduction Than Regular CBD, New Study
CANAQUEST MEDICAL CORP (OTCPK:CANQF), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous syst
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated substantially reduced seizures at higher doses, with less CBD, compared to standard CBD.TORONTO, ON / ACCESSWIRE / December 8
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
USERS REPORT INCREASED MENTAL CLARITY,BETTER SLEEP, MORE ENERGY, AND LESS BRAIN FOG AND JOINT STIFFNESSTORONTO, ON / ACCESSWIRE / September 8, 2022 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Comp
No More
Company Overview
More
CanaQuest Medical Corp. is a pharmaceutical company, which is focused on the medical cannabis products, utilizing cannabinoid molecules, and other botanical compounds. The firm as developed Mentanine, Omega3 compounds + CBD pharma grade isolate, which is used for mental health issues inside the central nervous system and Mentabinol, THC + L-Theanine formulation, which is an alternative to all other THC products, addressing anxiety, depression, schizophrenia, and post traumatic stress disorder. The company was founded by Paul Ramsay and Richard J. Rusiniak on October 7, 2008 and is headquartered in Mississauga, Canada.
CEO： --
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet